[A comparison of the efficacy of aminophylline and doxapram in preventing idiopathic apnea in preterm newborn infants].
Doxapram is an analeptic of the respiratory system that has been used in the last few years for the treatment of idiopathic apnea spells in infants who show resistance to methylxantine. In this study we have compared the efficacy of aminophylline and doxapram for the prevention of idiopathic apnea spells in two groups of preterm infants comparable for gestational age, birthweight and postnatal age. The two drugs resulted to be effective in preventing the spells of apnea in 66% and 60% of the cases respectively. In the cases in which there was a partial or negative response, the association of the two substances resulted in a noticeable reduction of the apnea spells. The positive effect of the association of aminophylline and doxapram is probably due to the different action mechanism on the stimulation of the respiratory system.
Romeo
M G
MG
Istituto di Clinica Pediatrica II, Università di Catania, Italia.
Proto
N
N
Tina
L G
LG
Parisi
M G
MG
Distefano
G
G
D000628:Aminophylline / Q000627:therapeutic use*; D001049:Apnea / Q000517:prevention & control*; D004315:Doxapram / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D013997:Time Factors; D014970:Xanthines / Q000037:antagonists & inhibitors
D014970:Xanthines; D000628:Aminophylline; C008514:methylxanthine; D004315:Doxapram
Comparazione dell'efficacia dell'Aminofillina e del Doxapram nella prevenzione della apnea idiopatica dei neonati pretermine.